4,655
Views
79
CrossRef citations to date
0
Altmetric
Review

Pathophysiology of essential hypertension: an update

, &
Pages 879-887 | Received 04 Mar 2018, Accepted 22 Oct 2018, Published online: 15 Nov 2018

References

  • Essential Hypertension-Wikipedia. [ cited 21 Nov 2018]. Available from: https://en.wikipedia.org/wiki/Essential_hypertension
  • Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003 Nov 4;139:761–776.
  • Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure.The JNC 7 report. JAMA. 2003 May 21;289:2560–2572.
  • Padmanabhan S, et al. Genomics of hypertension. Review article. Pharmacol Res. 2017 Jul;121:219–229. Epub 2017 May 8.
  • Fuentes RM, Notkola IL, Semeikka S, et al. Familial aggregation of blood pressure: a population based family study in eastern Finland. J Hum Hypertens. 2000;14:441–445.
  • Wilson FH, Kahle KT, Sabath E, et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na–cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci. 2003 Jan 21;100:680–684.
  • Mf BIANCHI. Genetic mechanisms underlying the regulation of urinary sodium excretion and arterial blood pressure: the role of adducin. Acta Physiol Scand. 2000;168:187–193.
  • Padmanabhan TN, Dani S, V.K. Chopra et al. Prevalence of sympathetic over activity in hypertensive patients–A pan India, non-interventional, cross sectional study. Indian Heart J. 2014;66:686.
  • Hart EC, Charkoudian N. Sympathetic neural mechanisms in human blood pressure regulation. Curr Hypertens Rep. 2011 Jun 1;13:237–243.
  • Smith PA, Graham LN, Mackintosh AF, et al. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol. 2002 Jul 3;40:126–132.
  • Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci. 2006;100:370–390.
  • De Leeuw PW, Kroon AA. Abnormal pressure-natriuresis in hypertension: role of nitric oxide. Acta Physiol Scand. 2013 sep;62:461–462.
  • Granger JP, Alexander BT .Abnormal pressure-natriuresis in hypertension: role of nitric oxide. Acta Physiol Scand. 2000 Jan;168(1):161-68.
  • Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545–551.
  • Rodriguez-Iturbe B, Romero F, Johnson RJ. Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis. 2007 Oct 1;50:655–672.
  • Mullins LJ, Bailey MA, Mullins JJ. Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev. 2006 Apr 1;86:709–746.
  • Victor RG, Kaplan NM. Systemic hypertension: mechanisms and diagnosis. Braunwald’s Heart Disease. 2008;8:1027.
  • Johnson RJ, Herrera-Acosta J, Schreiner GF, et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. New England J Med. 2002 Mar;21(346):913–923.
  • Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep. 2002 Mar 1;4:152–159.
  • Lüscher TF, Noll G, Nava E, et al. Endothelial Dysfunction and Hypertension. In: Vascular Endothelium in Human Physiology and Pathophysiology. 2014 Apr 21 (pp. 125-146). CRC Press. Available from: htttps://www.taylorfrancis.com.
  • Gkaliagkousi E, Douma S, Zamboulis C, et al. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. JHypertens. 2009;27:2310.
  • Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004 Aug;15:1983–1992.
  • Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–1310.
  • Flammer AJ, Lüscher TF. Human endothelial dysfunction: eDRFs. Pflugers Arch. 2010 May;459:1005–1013.
  • Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res. 2009;32:1103–1105.
  • Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293:H2009–23.
  • Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000;35:1270–1277.
  • Duprez DA. Role of the renin–angiotensin–aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens. 2006 Jun 1;24:983–989.
  • Hall J. E Pathophysiology of obesity hypertension. Curr Hypertens Rep. 2000;2:139–148.
  • Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension. Jan;45:9–15.
  • Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des. 2004;10:3621–3716.
  • Philips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61–66.
  • Trinder J, Kleiman J, Carrington M, et al. Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res. 2001;10:253–311.
  • Leuenberger U, Jacob E, Sweer L, et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol. 1995;79:581–587.
  • Okabe S, Hida W, Kikuchi Y, et al. Role of hypoxia on increased blood pressure in patients with obstructive sleep apnoea. Thorax. 1995;50:28–36.
  • Saxena TK, Maheshwari S, Saxena M. Aetiopathogenesis of type-2 diabetes mellitus: could chronic stress play an important role? J Assoc Physicians India. 2014;62:484–485.
  • Saxena T, Saxena M, Ali AO. Development of diabetes: possible role of potassium. Int J Diabetes Complications. 2017;1:1–5.
  • Lastra G, Dhuper S, Johnson MS, et al. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol. 2010;7:577–587.
  • Zhou MS, Schulman IH, Raij L. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am J Physiol Heart Circ Physiol. 2009;296:H833–H6.
  • Schulman IH, Zhou MS. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Curr Hypertens Rep. 2009;11:48–57.
  • Borghi C. Cicero Af giuseppe. Serum uric acid and cardio metabolic disease: another brick in the wall? Hypertension. 2017 jun;69:1011–1013.
  • Johnson RJ, Sanchez-Lozada LG, Mazzali M, et al. What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension. 2013;61:948–953.
  • Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012 Mar 14;3(1):7. doi:10.1186/2042-6410-3-7.
  • Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol. 2009 Aug 6:532–610.
  • Borrell LN, Menendez BS, Joseph SP. Racial/ethnic disparities on self-reported hypertension in New York City: examining disparities among Hispanic subgroups. Ethnicity and Disease. 2011 Sep 1;21(4):429.
  • Brondolo E, Love EE, Pencille M, et al. Racism and hypertension: a review of the empirical evidence and implications for clinical practice. Am J Hypertens. 2011;24(5):518–611.
  • Vaidya A, Forman JP. Vitamin D and hypertension current evidence and future directions. Hypertension. 2010;56:774–779.
  • Li YC, Kong J, Wei M, et al. 1, 25-Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002 Jul 15;110:229–238.
  • Munzel T, Gori T, Babisch W, et al. Cardiovascular effects of environmental noise exposure. Eur Heart J. 2014 Apr 1;35:829–839.
  • Zhang M, Mueller NT, Wang H, et al. Maternal Exposure to Ambient Particulate Matter≤ 2.5 µm during pregnancy and the risk of high blood pressure in childhood. Hypertension. 2018. Hypertensionaha 117.10944.
  • Smoking Talukder MH, Johnson Wm, S Varadharaj, et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiology-Heart Circulatory Physiol. 2010Nov5;300:H388–96.
  • Saxena T, Patidar S, Saxena M. Assessment of left ventricular ejection force and sympathetic skin response in normotensive and hypertensive subjects: A double-blind observational comparative case–control study. Indian Heart Journal. 2016 Sep 1;68(5):685-692. Available from: https://doi.org/10.1016/j.ihj.2015.12.005
  • Saxena T, Saxena M. Possible clinical implications of high left ventricular ejection force and exaggerated sympathetic skin response. Ann Clin Exp Hypertension. 2016;4:1035.
  • Saxena T, Mittal SR. Stress relaxation in management of mild to moderate Hypertension. Asian J Clin Cardiol. 2000;2:36–41.
  • Guyton AC, Hall JE. The autonomic nervous system. In: Text book of medical physiology. 13th ed. Philadelphia: Elsevier; 2016. p. 832–834.
  • Claus D, Schondorf R, Deuschl G, et al. Recommendations for the practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999;52:1–304.
  • Vetrugno R, Liguori R, Cortelli P, et al. Sympathetic skin response: basic mechanisms and clinical applications. ClinAuton Res. 2003;13:256–314.
  • Esler M. Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension. Hypertension. 2014;63:e25–e7.
  • Rossi GP, Bernini G,C Caliumi, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006 Dec5;48:2293–2300.
  • Thomos RM, Ruel E, Corsino L. Endocrine hypertension: an overview on the current etiopathogenesis and management options. World J Hypertens. 2015 May 23. Available from:“https://www.ncbi.nlm.nih.gov>articles” icporder=“ext-link-type;;xlink:href”

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.